Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

Tuesday Press Conference

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 2 of 2
Discussion of Oral Abstract Session 1 – SIV and HIV Pathogenesis and Oral Abstract Session 5 – Strategies for Testing and Linkage to Care: Are We Closing the Gap?
Chair
John Coffin
Tufts University, Medford, MA, United States
Chair
Susan P. Buchbinder
University of California, San Francisco, CA, United States
OA1: HIV-1 Laboratory Contagion During Recombination Procedures With Defective Constructs
Claudia Alteri
University of Rome Tor Vergata, Rome, Italy
OA5: Estimating the Lifetime Risk of a Diagnosis of HIV Infection in the United States
Kristen Hess
US Centers for Disease Control and Prevention, Atlanta, GA, United States
OA5: Increased HIV Viral Suppression Among US Adults Receiving Medical Care, 2009-2013
Heather Bradley
US Centers for Disease Control and Prevention, Atlanta, GA, United States
OA5: Narrowing the Gap in Life Expectancy for HIV+ Compared With HIV- Individuals
Julia L. Marcus
Kaiser Permanente Northern California, Oakland, CA, United States
OA5: Perception of Infectiousness in HIV-Infected Persons After Initiating ART: ACTG A5257
Raphael J. Landovitz
David Geffen School of Medicine, University of California, Los Angeles, CA, United States
from CROI 2016 on February 23, 2016 12:30 PM-1:30 PM
Discussion of Oral Abstract Session 3 – Prevention and Treatment of Pediatric HIV Infections
Chair
Elaine J. Abrams
Columbia University, New York, NY, United States
OA3: Impact of Option B+ on ART Uptake and Retention in Swaziland: A Stepped-Wedge Trial
Harriet Nuwagaba-Biribonwoha
ICAP, Columbia University Mailman School of Public Health, New York, NY, United States
OA3: National HIV Transmission in 4-12 Week Olds in Malawi's PMTCT Option B+ Program
Sundeep Gupta
CDC, Harare, Zimbabwe
OA3: Impact of Maternal Tenofovir Use on HIV-Exposed Newborn Bone Mineral
George K. Siberry
Eunice Kennedy Shriver NICHD, Bethesda, MD, United States
OA3: Similar Mortality With Cotrimoxazole vs Placebo in HIV-Exposed Uninfected Children
Roger L. Shapiro
Harvard School of Public Health, Boston, MA, United States
from CROI 2016 on February 23, 2016 12:30 PM-1:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 2 of 2